Detrimental effects of high-dose gonadotropin on outcome of IVF: Making a case for gentle ovarian stimulation strategies

Reproductive Sciences

Volumn 19, Issue 7, 2012, Pages 718-724

  Kovacs, Peter ^a   Sajgo, Attila ^a   Kaali, Steven G ^a   Pal, Lubna ^b  

^a Kaali Institute IVF Center   (Hungary)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clinical pregnancy; endometrial thickness; endometrium; gonadotropin dose; implantation; IVF

Indexed keywords

BUSERELIN; CETRORELIX; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; DRUG EFFECT; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; TREATMENT OUTCOME; UROGENITAL SYSTEM PARAMETERS;

ADULT; AGE FACTORS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO IMPLANTATION; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; HUNGARY; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 84863509733     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111432859     Document Type: Article

References (32)

1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006 ; 12 (6). 685-718
2. Inge GB, Brinsden PR, Elder KT. Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful?. Hum Reprod. 2005 ; 20 (3). 588-592
3. Revelli A, Casano S, Salvagno F, Delle Piane L. Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol. 2011 ; 16: 25-34
4. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypothesis. Endocr Rev. 1996 ; 17 (2). 121-155
5. Hoffmann GE, Toner JP, Muasher SJ, Jones GS. High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization. J In Vitro Fert Embryo Transf. 1989 ; 6 (5). 285-289
6. Blankstein J, Collins RL, Easley KA, Quigley MM. Increased human menopausal gonadotropin dose during the early follicular phase: effect on follicular recruitment and treatment outcome. J In Vitro Fert Emrbyo transf. 1989 ; 6 (2). 112-117
7. Loutradis D, Vomvolaki E, Drakakis P. Poor responder protocols for in-vitro fertilization: options and results. Curr Opin Obstet Gynecol. 2008 ; 20 (4). 374-378
8. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003 ; 9 (1). 61-76
9. Padilla SL, Dugan K, Maruschak V, Shalika S, Smith RD. Use of the flare-up protocol with high dose human follicle stimuzlating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril. 1996 ; 65 (4). 796-799
10. Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril. 2001 ; 76 (4). 666-669
11. Martin JR, Mahutte ND, Arici A, Sakkas D. Impact of duration and dose of gonadotropins on IVF outcomes. Reprod Biomed Online. 2006 ; 13 (5). 645-650
12. Lekamge DN, Lane M, Gilchrist RB, Tremellen KP. Increased gonadotropin stimulation does not improve IVF outcomes in patients with predicted poor ovarian response. J Assist Reprod Genet. 2008 ; 25 (11-12). 515-521
13. Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008 ; 89 (6). 1694-1701
14. Berkkanoglu M, Ozgur K. What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?. Fertil Steril. 2010 ; 94 (2). 662-665
15. Rubio C, Mercader A, Alama P, et al. Prospective cohort study in high responder oocyte donors using two hormonal stimulation protocols: impact on embryo aneuploidy and development. Hum Reprod. 2010 ; 25: 2290-2297
16. Baart EB, Martini E, Eijkemans MJ, et al. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod. 2007 ; 22 (4). 980-988
17. Liu Y, Lee KF, Ng EH, Yeung WS, Ho PC. Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles. Fertil Steril. 2008 ; 90 (6). 2152-2164
18. Horcajadas JA, Riesewijk A. Polman J, et al. effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod. 2005 ; 11 (3). 195-205
19. Martinez-Conjero JA, Simon C, Pellicier A, Horcajadas JA. Is ovarian stimulation detrimental to the endometrium?. Reprod Biomed Online. 2007 ; 15 (1). 45-50
20. The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF/ICSI. Hum Reprod. 2004 ; 19 (8). 1713-1718
21. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992 ; 340 (8810). 17-18
22. Baczkowski T, Kurzawa R, Głabowski W. Methods of embryo scoring in in vitro fertilization. Reprod Biol. 2004 ; 4 (1). 5-22
23. Bewick V, Cheek L, Ball J. Statistics review 14: logistic regression. Crit Care. 2005 ; 9 (1). 112-118
24. Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab. 2003 ; 88 (1). 166-173
25. Mirkin S, Arslan M, Churikov D, et al. In search of candidate genes critically expressed in the human endometrium during the window of implantation. Hum Reprod. 2005 ; 20 (8). 2104-2117
26. van der Gaast MH, Classen-Linke I, Krusche CA, et al. Impact of ovarian stimulation on mid-luteal endometrial tissue and secretion markers of receptivity. Reprod Biomed Online. 2008 ; 17 (4). 553-563
27. Kovacs P, Matyas S, Boda K, Kaali SG. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod. 2003 ; 18 (11). 2337-2341
28. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online. 2007 ; 14 (5). 640-649
29. Milki AA, Hinckley MD, Fisch JD, Dasig D, Behr B. Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations. Fertil Steril. 2000 ; 73 (1). 126-129
30. Blake DA, Farquhar CM, Johnson N, Proctor M. Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev. 2007 ; 17 (4). CD002118
31. Johnson NP, Sadler L, Merrilees M. IVF and tubal pathology-not all bad news. Aust N Z J Obstet Gynaecol. 2002 ; 42 (3). 285-288
32. Ozmen B, Diedrich K, Al-Hasani S. Hydrosalpinx and IVF: assessment of treatments implemented prior to IVF. Reprod Biomed Online. 2007 ; 14 (2). 235-241